Recent Company News

• 09:02 AM ET Aug 13, 2025
  

  Connect Biopharma Holdings reports Q2 net income ($12.9M) vs year-ago $14.8M ($2.27, 0.00)

• 09:15 AM ET Jul 09, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:22 AM ET Jul 28, 2025
  

  StreetAccount Summary - US Pre-market trading

• 05:07 PM ET Jul 22, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 10:20 AM ET Jul 22, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (80 total)

• 08:57 AM ET Jul 22, 2025
  

  Connect Biopharma Holdings initiated outperform at Northland Capital Markets ($2.00, 0.00)

• 09:01 AM ET Jul 21, 2025
  

  Connect Biopharma announces plans to terminate ADR program and directly list its ordinary shares on Nasdaq ($1.72, 0.00)

• 09:04 AM ET Jul 09, 2025
  

  Connect Biopharma Holdings issues press release on Simcere Pharmaceutical's submission of its NDA for rademikibart for the treatment of atopic dermatitis in China ($1.13, 0.00)